CLIMB BIO, INC. (CLYM) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$15.33M*; Operating income -$15.36M; Depreciation and amortization $33.00K*.
- 2026-03-31: Basis Reported; EBITDA -$15.17M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA -$19.27M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA -$14.86M*; Operating income -$14.89M; Depreciation and amortization $29.00K*.
Complete source-backed ebitda history.
- Available history
- 2024-12-31 to 2026-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$15.33M* | -$15.36M | $33.00K* | (m) | (m) | (m) | -$10.55M* | (m) | $9.71M | (m) | (m) |
|---|
| 2026-03-31 | Reported | -$15.17M | (m) | (m) | (m) | (m) | (m) | -$14.38M | (m) | $9.37M | (m) | (m) |
|---|
| 2025-12-31 | Reported | -$19.27M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | -$14.86M* | -$14.89M | $29.00K* | (m) | (m) | $109.00K* | -$12.14M* | (m) | $9.07M | (m) | (m) |
|---|
| 2025-06-30 | Reported | -$10.64M* | -$10.68M | $38.00K* | (m) | (m) | (m) | -$11.15M* | (m) | $6.58M | (m) | (m) |
|---|
| 2025-03-31 | Reported | -$23.02M | (m) | (m) | (m) | (m) | (m) | -$15.43M | (m) | $17.33M | (m) | $0.00 |
|---|
| 2024-12-31 | Reported | -$10.91M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | -$11.73M* | -$11.73M | $0.00* | (m) | (m) | $0.00* | -$7.55M* | (m) | $6.24M | (m) | $0.00 |
|---|
| 2024-06-30 | Reported | (m) | -$56.37M | (m) | (m) | (m) | (m) | -$667.00K* | (m) | $1.05M | (m) | $0.00* |
|---|
| 2024-03-31 | Reported | (m) | -$3.00M | (m) | (m) | (m) | (m) | -$1.82M | (m) | $1.09M | (m) | $0.00 |
|---|
| 2023-09-30 | Reported | (m) | -$5.00M | (m) | (m) | (m) | (m) | $3.49M* | (m) | $2.88M | (m) | $0.00 |
|---|
| 2023-06-30 | Reported | (m) | -$6.71M | (m) | (m) | (m) | (m) | -$7.96M* | (m) | $3.69M | (m) | $0.00* |
|---|
| 2023-03-31 | Reported | (m) | -$23.44M | (m) | (m) | (m) | (m) | -$15.18M | (m) | $5.72M | (m) | $0.00 |
|---|
| 2022-09-30 | Reported | (m) | -$8.75M | (m) | (m) | (m) | (m) | -$4.17M* | (m) | $4.26M | (m) | $0.00* |
|---|
| 2022-06-30 | Reported | (m) | -$13.70M | (m) | (m) | (m) | (m) | -$13.97M* | (m) | $8.77M | (m) | $0.00* |
|---|
| 2022-03-31 | Reported | (m) | -$13.13M | (m) | (m) | (m) | (m) | -$10.78M | (m) | $8.26M | (m) | $0.00 |
|---|
| 2021-09-30 | Reported | (m) | -$9.38M | (m) | (m) | (m) | (m) | -$12.97M* | (m) | $5.99M | (m) | (m) |
|---|
| 2021-06-30 | Reported | (m) | -$8.71M | (m) | (m) | (m) | (m) | -$8.48M* | (m) | $5.48M | (m) | (m) |
|---|
| 2021-03-31 | Reported | (m) | -$6.88M | (m) | (m) | (m) | (m) | -$6.74M | (m) | $4.27M | (m) | (m) |
|---|
| 2020-09-30 | Reported | (m) | -$2.26M | (m) | (m) | (m) | (m) | -$2.38M* | (m) | $1.93M | (m) | (m) |
|---|
| 2020-06-30 | Reported | (m) | -$1.61M | (m) | (m) | (m) | (m) | (m) | (m) | $1.32M | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | -$67.79M | (m) | (m) | (m) | (m) | $186.00K | -$54.36M | (m) | $46.71M | (m) | $0.00 |
|---|
| 2024-12-31 | Reported | -$82.02M | (m) | (m) | (m) | (m) | $0.00 | -$15.56M | (m) | $14.34M | (m) | $0.00 |
|---|
| 2023-12-31 | Reported | (m) | -$40.27M | (m) | (m) | (m) | (m) | -$20.60M | (m) | $15.41M | (m) | $0.00 |
|---|
| 2022-12-31 | Reported | (m) | -$45.13M | (m) | (m) | (m) | (m) | -$37.37M | (m) | $26.21M | (m) | $0.00 |
|---|
| 2021-12-31 | Reported | (m) | -$35.67M | (m) | (m) | (m) | (m) | -$36.07M | (m) | $23.32M | (m) | $0.00 |
|---|
| 2020-12-31 | Reported | (m) | -$20.93M | (m) | (m) | (m) | (m) | -$14.10M | (m) | $8.77M | (m) | $0.00 |
|---|